VERAXA Biotech and Voyager file F-4 registration for merger
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/11/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Wall Street ends higher as investors turn to earnings season
- AppLovin gains market share among e-commerce advertisers
VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC
July 17, 2025 8:55 AM EDTZURICH, July 17, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (VERAXA or the "Company"), an emerging leader in designing novel cancer therapies, and Voyager Acquisition Corp., Â a Cayman Islands exempted company and special purpose acquisition company targeting the healthcare sector (NASDAQ:VACH, Voyager or... More
